The ACT EU initiative aims toidentify gaps, issues and bottlenecks(regulatory, resourcing, operational) that prevent non-commercial sponsors from setting up and conducting clinical trials and multinational trials in particular. The programme intends to establish an action plan withclear measures in place to support non-commercial sponsorsacross the European Union / European Economic Area by: The helpdesk employs different measures to assist sponsors in navigating the clinical trial landscape in the European Union (EU). Currently, the helpdesk offers tailored technical assistance on CTIS functionalities and addresses questions on regulatory requirements related to the clinical trial lifecycle. The helpdesk may also consult National
ACT EU - Accelerating Clinical Trials · May 08, 2026
ACT EU: Support for non-commercial sponsors
Original title: Support for non-commercial sponsors
ACT EU initiative establishes helpdesk and action plan to identify and address regulatory, resourcing and operational bottlenecks for non-commercial clinical trial sponsors across EU/EEA.
Published by ACT EU - Accelerating Clinical Trials. HealthSignal links to the original document; the summary above is extracted from the source text.